0001127602-20-015653.txt : 20200506
0001127602-20-015653.hdr.sgml : 20200506
20200506171415
ACCESSION NUMBER: 0001127602-20-015653
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200504
FILED AS OF DATE: 20200506
DATE AS OF CHANGE: 20200506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nally Michael
CENTRAL INDEX KEY: 0001763945
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 20853604
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-05-04
0000310158
Merck & Co., Inc.
MRK
0001763945
Nally Michael
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
1
EVP, Chief Marketing Officer
Common Stock
2020-05-04
4
M
0
1298
77.67
A
10273.935
D
Common Stock
2020-05-04
4
F
0
565
77.67
D
9708.935
D
Common Stock
2020-05-05
4
M
0
2345
76.86
A
12053.935
D
Common Stock
2020-05-05
4
F
0
1020
76.86
D
11033.935
D
Common Stock - 401(k) Plan
1720.848
I
By 401(k)
Restricted Stock Unit
2020-05-04
4
M
0
1298
0
D
2019-05-04
2021-05-04
Common Stock
1298
1300
D
Restricted Stock Unit
2020-05-05
4
M
0
2345
0
D
2020-05-05
2020-05-05
Common Stock
2345
0
D
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends earned through April 7, 2020, in the Merck U.S. Savings Plan, a 401(k) plan.
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
/s/ Faye C. Brown as Attorney-in-Fact for Michael Nally
2020-05-06